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in an HIV-infected patient
Penicillium marneffei is an AIDS-defining endemic mycosis in
Southeast Asia. Patients usually present with fever, weight
loss, mucocutaneous lesions, lymphadenopathy, hepatome-
galy, or pulmonary infiltrates.1 We hereby report the first
case of asymptomatic P. marneffei fungemia in an HIV-
infected patient.
A 47-year-old male was admitted on July 6, 2002 for one
week’s history of dyspnea. He had been receiving isoniazid,
rifampin, pyrazinamide, and ethambutol for threemonths for
treatment of disseminated tuberculosis affecting the lung,
terminal ileum, mesenteric lymph nodes, and peritoneum
(key clinical and laboratory findings are summarized in
Table 1). On admission, he was hypoxic with a temperature
of 37.8 8C. There were fine crepitations over bilateral lung
bases and a chest radiograph showed bilateral ground-glass
infiltrates. Cultures of sputum, bronchoalveolar lavage, and
blood were all negative for bacteria and acid-fast bacilli, but
transbronchial biopsy confirmed Pneumocystis jiroveci pneu-
monitis. No fungal pathogens were seen in the sections or
bronchoalveolar lavage. Serology for HIV-1 was positive by
enzyme-linked immunosorbent and Western blot assays. His
CD4+ T-lymphocyte count was 81 cells/mL with a viral load of
100 000 copies/mL. The pneumonitis responded well to two
weeks of cotrimoxazole, and he was discharged completely
asymptomatic. However, a blood culture taken on the first
day of this admission (BACTEC Myco/F Lytic culture bottle,
BACTEC 9000, Becton—Dickinson, Maryland, USA), intended
for detection of mycobacteria in blood, was positive for aTable 1 Summary of clinical events and laboratory findings of th
Date Clinical events
April 4, 2002 Weight loss; right lower abdominal mass;
computed tomography showed thickened
bowel wall at terminal ileum with enlarg
mesenteric lymph nodes
April 5, 2002 Started anti-tuberculous treatment with
rifampin, isoniazid, ethambutol, and pyra
April 22, 2002 Sudden onset of epigastric pain with
peritonism; laparotomy found perforated
terminal ileum with pelvic abscess
June 8, 2002 Discharged home; continued
anti-tuberculous treatment
July 6, 2002 Dyspnea and hypoxemia
July 7, 2002 Blood culture taken
July 10, 2002 HIV serology checked
July 13, 2002 Discharged home
August 16, 2002 Blood taken on July 7, 2002 reported pos
for P. marneffei
August 22, 2002 Readmitted for clinical evaluation of asym
P. marneffei fungemia
September 7, 2002 Started itraconazole
September 20, 2002 Discharged home and referred to AIDS cli
October 17, 2002 Started antiretroviral treatment with ind
ritonavir, and combivirfungusfiveweeks later. Subcultures on Sabouraud agar showed
thermal dimorphism with yeast-like colonies and mould form
at 37 8C and 25 8C, respectively. A diffusible red pigment was
noted in the mould culture, which was characteristic of P.
marneffei (Figure 1). There were no mucocutaneous lesions,
lymphadenopathy, or hepatosplenomegaly at any time.
Repeated chest radiographs showed marked improvement
without any hilar shadows. Repeated blood cultures were
negative. Despite the negative physical findings, oral itraco-
nazole 200 mg twice dailywas given for twoweeks followed by
200 mg daily for maintenance. The patient did not develop
overt penicilliosis in the following 34 months.
Penicilliosis is a potentially fatal opportunistic infection in
AIDS patients and its classical manifestations have been
described.1 However, our patient has several notable features
that are different from the previously reported cases. Firstly,
heremainedasymptomaticdespitetheepisodeofdocumented
fungemia.The isolationofP.marneffei shouldbeconsideredas
genuine fungemia as the fungus has never been known to cause
contamination of blood cultures. Secondly, the fungemia
appeared to be transient as the fungus was not isolated from
the patient again even before the antifungal agent was given.
Asymptomatic fungal infectionshavebeenreported inpatients
with pulmonary cryptococcosis and paracoccidioidomyco-
sis.2,3 This case suggests that transient asymptomatic P. mar-
neffei fungemia is also possible. From a previously reported
serological study, there could be a significant number of
clinically asymptomatic individuals infectedwithP.marneffei,
particularly among those living in endemic areas.4 Similarly, an
immunocompromised patient with Waldenstro¨m’s macroglo-
bulinemia developed mixed Candida tropicalis and P. marnef-e patient
Laboratory findings
ed
Stool showed acid-fast bacilli on
Ziehl—Neelsen stain; stool and
sputum grew Mycobacterium tuberculosis
zinamide
Peritoneal swab grew M. tuberculosis
Transbronchial biopsy found Pneumocystis
jiroveci. All other cultures were negative.
Grew Penicillium marneffei after 5 weeks
of incubation
Positive HIV-1 serology
itive
ptomatic Two sets of blood culture repeated and
remained negative after 8 weeks of incubation
nic
inavir,
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Figure 1 Penicillium marneffei isolated from the patient’s
blood. Panel A shows the septated hyphae first found in the
blood culture after five weeks. Panel B shows the distinctive
diffusible red pigment from the mould when subcultured at room
temperature on Sabouraud agar.fei fungemia during hospitalization, pointing to the possibility
of reactivation of a latent infection.5 We postulate that in HIV-
infected patients, asymptomatic P. marneffei infection could
have occurred earlier in life and the fungus may remain latent
thereafter. As the course of HIV infection progresses and the
patient becomes increasingly immunocompromised, or when
immunosuppressing diseases occur in HIV-negative patients,
the latent infection may develop into overt penicilliosis. HIV
patients living in, or those with a history of traveling to areas
where P. marneffei is endemic should ideally be tested forprevious exposure to the fungus and primary antifungal pro-
phylaxis be considered. Unfortunately, there are currently no
good tests available for this purpose, and seropositivity alone
cannot differentiate past infection from latency. A positive
fungal culture, even in the absence of the typical manifesta-
tions of penicilliosis, should be considered as clinically signifi-
cant and antifungal treatment and/or prophylaxis should be
considered. Further studies would be required to prove that
antifungal prophylaxis is beneficial in preventing the develop-
ment of overt penicilliosis from latent infections.
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doi:10.1016/j.ijid.2006.04.004Pseudomonas infection of implantable cardio-
verter-defibrillator generator and leads as a
complication of gastrostomy
A 59-year-old Caucasian male with a history of coronary
artery disease, severe chronic obstructive pulmonary dis-
ease, heart failure, bladder and prostate carcinoma, and
an implanted cardioverter-defibrillator (ICD), was referredto our institution for further treatment of an infected ICD
pocket. An ICD was implanted in an abdominal pocket in 1993
and had been changed three times since due to lead fracture
or battery dysfunction. The third placement was in the left
pectoral region 18 months prior to admission.
Six weeks prior to admission, the patient was admitted to
a local hospital with acute bronchitis. A percutaneous endo-
scopic gastrostomy (PEG) tube was placed due to aspiration,
medial to the old ICD abdominal pocket. Shortly after, a
